Cargando…
The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes
Type 1 diabetes (T1D) remains a major health problem worldwide, with a steadily rising incidence yet no cure. Phosphoinositide 3-kinase-γ (PI3Kγ), a member of a family of lipid kinases expressed primarily in leukocytes, has been the subject of substantial research for its role in inflammatory diseas...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357271/ https://www.ncbi.nlm.nih.gov/pubmed/22403300 http://dx.doi.org/10.2337/db11-0134 |
_version_ | 1782233651027640320 |
---|---|
author | Azzi, Jamil Moore, Robert F. Elyaman, Wassim Mounayar, Marwan El Haddad, Najib Yang, Sunmi Jurewicz, Mollie Takakura, Ayumi Petrelli, Alessandra Fiorina, Paolo Ruckle, Thomas Abdi, Reza |
author_facet | Azzi, Jamil Moore, Robert F. Elyaman, Wassim Mounayar, Marwan El Haddad, Najib Yang, Sunmi Jurewicz, Mollie Takakura, Ayumi Petrelli, Alessandra Fiorina, Paolo Ruckle, Thomas Abdi, Reza |
author_sort | Azzi, Jamil |
collection | PubMed |
description | Type 1 diabetes (T1D) remains a major health problem worldwide, with a steadily rising incidence yet no cure. Phosphoinositide 3-kinase-γ (PI3Kγ), a member of a family of lipid kinases expressed primarily in leukocytes, has been the subject of substantial research for its role in inflammatory diseases. However, the role of PI3Kγ inhibition in suppressing autoimmune T1D remains to be explored. We tested the role of the PI3Kγ inhibitor AS605240 in preventing and reversing diabetes in NOD mice and assessed the mechanisms by which this inhibition abrogates T1D. Our data indicate that the PI3Kγ pathway is highly activated in T1D. In NOD mice, we found upregulated expression of phosphorylated Akt (PAkt) in splenocytes. Notably, T regulatory cells (Tregs) showed significantly lower expression of PAkt compared with effector T cells. Inhibition of the PI3Kγ pathway by AS605240 efficiently suppressed effector T cells and induced Treg expansion through the cAMP response element-binding pathway. AS605240 effectively prevented and reversed autoimmune diabetes in NOD mice and suppressed T-cell activation and the production of inflammatory cytokines by autoreactive T cells in vitro and in vivo. These studies demonstrate the key role of the PI3Kγ pathway in determining the balance of Tregs and autoreactive cells regulating autoimmune diabetes. |
format | Online Article Text |
id | pubmed-3357271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-33572712013-06-01 The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes Azzi, Jamil Moore, Robert F. Elyaman, Wassim Mounayar, Marwan El Haddad, Najib Yang, Sunmi Jurewicz, Mollie Takakura, Ayumi Petrelli, Alessandra Fiorina, Paolo Ruckle, Thomas Abdi, Reza Diabetes Immunology and Transplantation Type 1 diabetes (T1D) remains a major health problem worldwide, with a steadily rising incidence yet no cure. Phosphoinositide 3-kinase-γ (PI3Kγ), a member of a family of lipid kinases expressed primarily in leukocytes, has been the subject of substantial research for its role in inflammatory diseases. However, the role of PI3Kγ inhibition in suppressing autoimmune T1D remains to be explored. We tested the role of the PI3Kγ inhibitor AS605240 in preventing and reversing diabetes in NOD mice and assessed the mechanisms by which this inhibition abrogates T1D. Our data indicate that the PI3Kγ pathway is highly activated in T1D. In NOD mice, we found upregulated expression of phosphorylated Akt (PAkt) in splenocytes. Notably, T regulatory cells (Tregs) showed significantly lower expression of PAkt compared with effector T cells. Inhibition of the PI3Kγ pathway by AS605240 efficiently suppressed effector T cells and induced Treg expansion through the cAMP response element-binding pathway. AS605240 effectively prevented and reversed autoimmune diabetes in NOD mice and suppressed T-cell activation and the production of inflammatory cytokines by autoreactive T cells in vitro and in vivo. These studies demonstrate the key role of the PI3Kγ pathway in determining the balance of Tregs and autoreactive cells regulating autoimmune diabetes. American Diabetes Association 2012-06 2012-05-14 /pmc/articles/PMC3357271/ /pubmed/22403300 http://dx.doi.org/10.2337/db11-0134 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Immunology and Transplantation Azzi, Jamil Moore, Robert F. Elyaman, Wassim Mounayar, Marwan El Haddad, Najib Yang, Sunmi Jurewicz, Mollie Takakura, Ayumi Petrelli, Alessandra Fiorina, Paolo Ruckle, Thomas Abdi, Reza The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes |
title | The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes |
title_full | The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes |
title_fullStr | The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes |
title_full_unstemmed | The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes |
title_short | The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes |
title_sort | novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor as605240 in autoimmune diabetes |
topic | Immunology and Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357271/ https://www.ncbi.nlm.nih.gov/pubmed/22403300 http://dx.doi.org/10.2337/db11-0134 |
work_keys_str_mv | AT azzijamil thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT moorerobertf thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT elyamanwassim thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT mounayarmarwan thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT elhaddadnajib thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT yangsunmi thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT jurewiczmollie thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT takakuraayumi thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT petrellialessandra thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT fiorinapaolo thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT rucklethomas thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT abdireza thenoveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT azzijamil noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT moorerobertf noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT elyamanwassim noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT mounayarmarwan noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT elhaddadnajib noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT yangsunmi noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT jurewiczmollie noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT takakuraayumi noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT petrellialessandra noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT fiorinapaolo noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT rucklethomas noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes AT abdireza noveltherapeuticeffectofphosphoinositide3kinaseginhibitoras605240inautoimmunediabetes |